Skip to main content

MoneyWorks4Me

Dr. Reddy’s Laboratories informs about press release

01 Aug 2026 Evaluate
Dr. Reddy’s Laboratories has informed that it enclosed a Press Release, ‘Dr. Reddy's Laboratories Receives U.S. FDA Approval for Rituximab Biosimilar’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..